Diploma (LON:DPLM) Trading 15.1% Higher – Still a Buy?

Diploma PLC (LON:DPLM)’s share price was up 15.1% during trading on Wednesday . The stock traded as high as GBX 5,025 ($67.30) and last traded at GBX 4,860 ($65.09). Approximately 975,747 shares changed hands during mid-day trading, an increase of 115% from the average daily volume of 453,933 shares. The stock had previously closed at GBX 4,222 ($56.54).

Diploma Price Performance

The company has a market cap of £6.48 billion, a P/E ratio of 55.86, a P/E/G ratio of 2.82 and a beta of 0.75. The stock has a 50-day simple moving average of GBX 3,949.28 and a 200 day simple moving average of GBX 4,253.28. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17.

Diploma (LON:DPLM) last issued its earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.07) EPS for the quarter. Diploma had a return on equity of 13.18% and a net margin of 9.25%. On average, equities analysts expect that Diploma PLC will post 163.7995512 EPS for the current year.

Insider Buying and Selling at Diploma

In other Diploma news, insider David S. Lowden purchased 750 shares of the business’s stock in a transaction on Friday, March 21st. The stock was purchased at an average price of GBX 3,928 ($52.60) per share, for a total transaction of £29,460 ($39,453.60). Also, insider Ian El-Mokadem acquired 500 shares of the stock in a transaction dated Monday, March 24th. The stock was bought at an average price of GBX 3,948 ($52.87) per share, for a total transaction of £19,740 ($26,436.32). Insiders own 0.52% of the company’s stock.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.